{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:58:42Z","timestamp":1740146322830,"version":"3.37.3"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health Research, Doctoral Research Fellowship","award":["DRF-2015-08-048"],"award-info":[{"award-number":["DRF-2015-08-048"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196200","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T13:28:34Z","timestamp":1524835714000},"page":"e0196200","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6324-6559","authenticated-orcid":true,"given":"Merryn","family":"Voysey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrijana","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Thorson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Fanshawe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"ref1","article-title":"The Antibody Response Following a Booster with Either a 10-Or 13-Valent Pneumococcal Conjugate Vaccine in Toddlers Primed with a 13-Valent Pneumococcal Conjugate Vaccine in Early Infancy","author":"J Tr\u00fcck","year":"2016","journal-title":"Ped Infect Dis J"},{"issue":"17","key":"ref2","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0264-410X(03)00025-2","article-title":"Correlates of immunity for pneumococcal conjugate vaccines","volume":"21","author":"LH Lee","year":"2003","journal-title":"Vaccine"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1128\/CVI.05313-11","article-title":"Prediction of pneumococcal conjugate vaccine effectiveness against invasive pneumococcal disease using opsonophagocytic activity and antibody concentrations determined by enzyme-linked immunosorbent assay with 22F adsorption","volume":"18","author":"L Schuerman","year":"2011","journal-title":"Clin Vaccin Immunol"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jinf.2009.12.008","article-title":"Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996\u20132006","volume":"60","author":"CL Trotter","year":"2010","journal-title":"J Infect"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(15)70007-1","article-title":"Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial","volume":"15","author":"M Hamaluba","year":"2015","journal-title":"The Lancet Infect Dis"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ijid.2010.05.021","article-title":"The burden of vaccine-preventable invasive bacterial infections and pneumonia in children admitted to hospital in urban Nepal","volume":"15","author":"DF Kelly","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"Supplement 2","key":"ref7","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1086\/596490","article-title":"Invasive pneumococcal disease in Kanti Children's Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance network","volume":"48","author":"A Shah","year":"2009","journal-title":"Clinl Infect Dis"},{"key":"ref8","article-title":"Epidemiology of Invasive Pneumococcal Disease in Bangladeshi Children Before Introduction of Pneumococcal Conjugate Vaccine","author":"SK Saha","year":"2015","journal-title":"Ped Infect Dis Journal"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"e98796","DOI":"10.1371\/journal.pone.0098796","article-title":"Pneumococcal serotypes and serogroups causing invasive disease in Pakistan, 2005\u20132013","volume":"9","author":"S Shakoor","year":"2014","journal-title":"PloS one"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/505710","article-title":"Capsular serotype\u2013specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children","volume":"194","author":"KL Sleeman","year":"2006","journal-title":"J Infect Dis"},{"year":"2010","author":"J Fox","key":"ref11"},{"article-title":"Applied multivariate data analysis: volume II: Categorical and Multivariate Methods","year":"2012","author":"J Jobson","key":"ref12"},{"year":"2015","key":"ref13"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"e1000348","DOI":"10.1371\/journal.pmed.1000348","article-title":"Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project","volume":"7","author":"HL Johnson","year":"2010","journal-title":"PLoS Med"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype-and clone-specific differences in invasive disease potential","volume":"187","author":"AB Brueggemann","year":"2003","journal-title":"J Inf Dis"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"e0114286","DOI":"10.1371\/journal.pone.0114286","article-title":"Multi-serotype pneumococcal nasopharyngeal carriage prevalence in vaccine naive Nepalese children, assessed using molecular serotyping","volume":"10","author":"R Kandasamy","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/381686","article-title":"Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae","volume":"189","author":"A Sandgren","year":"2004","journal-title":"J Infect Dis"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/infdis\/jis447","article-title":"Rates of acquisition and clearance of pneumococcal serotypes in the nasopharynges of children in Kilifi District, Kenya","volume":"206","author":"O Abdullahi","year":"2012","journal-title":"J Infect Dis"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/00006454-200110000-00009","article-title":"Evolution of S treptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vig\u00eda Group, 1993 to 1999","volume":"20","author":"JL Di Fabio","year":"2001","journal-title":"Ped Infect Dis J"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I","volume":"30","author":"WP Hausdorff","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T12:09:55Z","timestamp":1540037395000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196200"}},"subtitle":[],"editor":[{"given":"Thomas L.","family":"Richie","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196200","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,4,27]]}}}